Fig. 3From: Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyondImmunotherapies for AD in ongoing clinical trials. Immunotherapies for different stages of AD progression are shown. Most of the current immunization therapies target the early phase of ADBack to article page